T1	Participants 122 177	clomiphene-citrate-resistant polycystic ovary syndrome.
T2	Participants 351 413	clomiphene-citrate-resistant polycystic ovary syndrome (PCOS).
T3	Participants 484 583	Dhaka Medical College and Hospital and the Infertility Care and Research Centre, Dhaka, Bangladesh.
T4	Participants 595 710	165 infertile patients with CC-resistant PCOS who attended for treatment were the target population for this study.
T5	Participants 1756 1765	safely in
